Beta-adrenergic blocking drugs were thefirst agents shown in large clinical trials toimprove the outcomes of survivors of acutemyocardial infarction (MI). Lower mortalitywas observed in the group ...
Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (Beta-blockers) compared with periods that they are not taking the medication, a new study finds. If the findings ...
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Share on Pinterest Beta-blockers may not help reduce additional cardiovascular health risks for people after they’ve had a heart attack. grandriver/Getty Images A new study has found that taking ...
In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity. In a new study, ...
ASTHMA can be defined as a disease of the bronchi producing diffuse, reversible bronchial obstruction. The bronchial tree of patients with asthma is hypersensitive to the effects of dust, cold air, ...
CHF remains a common cause of morbidity and mortality in the United States. Several neurohormonal systems are involved in the pathogenesis and progression of CHF. Oxidative stress contributes to ...
Beta-blockers are used to treat some heart conditions. Some beta-blockers may not be good for people with chronic obstructive pulmonary disease (COPD), but new research has found that certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results